The United States Food and Drug Administration inspected Aurobindo Pharma Ltd s wholly owned subsidiary, APL Health Care Limited s Unit I & III and issued a Form 483 with 2 observations.
Panchkula (Haryana) [India], January 10 (ANI/BusinessWire India): The dermatology business is becoming a fiercely competitive space as many companies are vying for a Market share, growth, profit, and customers. It is a field constantly evolving due to the adaptation of new technologies, changes in the regulatory environment, and research and development of new products and technology. According to the report published by Mordor Intelligence, The global dermatology market in 2018 was valued at $42.1 billion and by 2024 is expected to reach $72.6 billion, growing at a CAGR of 9.0% during the forecast period. Derma Manufacturing and Franchise is among the most lucrative business in Dermatology Sector. PharmaHopers, India's Leading B2B Pharma Portal, has many derma PCD Franchise and Derma Manufacturing companies listed on it. PharmaHopers are used by pharmaceutical manufacturers, wholesalers, distributors, and retailers to find suppliers, source products, and manage supply chains. Apar